34 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

Point of Care POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Technology( Lateral Flow, Agglutination Assays, Flow Through, Solid Phase, and Others), By Application( Tropical...

  • Infectious Disease
  • Managed Care
  • Diagnostics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Plant-made vaccines are also helping to fight against Chagas disease and other tropical diseases.

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Middle East
  • Health Expenditure
  • Mortality Rate

Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (RDTs, Microscopy, Molecular Diagnostic Tests), By Region (Eastern Mediterranean, Southeast Asia, Africa), And Segment Forecasts, 2019 - 2026 The global malaria diagnostics market size is projected to reach USD 998.85 million by 2026 expanding...

  • Malaria
  • Diagnostics
  • Molecular Diagnostics
  • World
  • Africa
  • Southeast Asia
  • Eastern Mediterranean

There has been a massive burden of various communicable, non-communicable and tropical diseases across the Middle East & Africa region.

  • Pharmaceutical
  • Biotechnology
  • Infectious Disease
  • Beverage
  • Middle East
  • Africa
  • Health Expenditure
  • Final Consumption Expenditures

Biosy nex's products are used in the therapeutic areas such as infectious diseases, emergency markers, obstetric, parasitology and virology, tropical diseases, and autoimmune diseases, among others.

  • Infectious Disease
  • Clinical Trial
  • World
  • India
  • Zhejiang
  • Pneumonia Prevalence
  • Direct Sales

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Encephalitis
  • Drug Development
  • Japan
  • Health Provider Density
  • Infectious Disease Mortality

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Drug Development
  • World
  • India
  • China
  • Health Provider Density
  • Hospital Discharge

Island Pharmaceuticals is a biotechnology company that has a rapid and efficient development strategy to develop tropical disease therapies.

  • Infectious Disease
  • Drug Development
  • World
  • Asia
  • India
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

In June 2013, Aix-Marseille Universite f iled a patent EP##.## titled "A new chemical f amily to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • World
  • Northern Europe
  • Japan
  • Cause-Specific Mortality Rate
  • Hospital Discharge

In June 2013, Aix-Marseille Universite f iled a patent EP##.## titled "A new chemical f amily to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Encephalitis
  • Japan
  • Biologics Penetration Rate
  • Infectious Disease Mortality

In October 2014, Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tuberculosis (TB) that have been discovered at the Novartis Institutes for Tropical Diseases (NITD).

  • Tuberculosis
  • Drug Development
  • World
  • South Africa
  • India
  • Sichuan
  • Chongqing Municipality
  • Guangdong
  • Tibet
  • Drug Approval
  • Stem Cell Transplantation

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • World
  • Northern Europe
  • Japan
  • Health Provider Density

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Encephalitis
  • Japan
  • Biologics Penetration Rate
  • Health Provider Density

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • World
  • Japan
  • Hawaii
  • South Africa
  • Drug Approval
  • Health Provider Density

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Drug Development
  • World
  • United States
  • Asia
  • Japan
  • India
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

In September 2010, Themis Bioscience formed a joint R&D program collaboration with Institut Pasteur to fight tropical infectious diseases including chickungunya.

  • Infectious Disease
  • Drug Development
  • World
  • Toyama Prefecture
  • Drug Approval
  • Pharmaceutical Registrations

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • United States
  • Japan
  • Drug Approval
  • Pharmaceutical Registrations

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Japan
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

In September 2010, Themis Bioscience formed a joint R&D program collaboration with Institut Pasteur to fight tropical infectious diseases including chickungunya.

  • Infectious Disease
  • World
  • India
  • Hawaii
  • Drug Approval
  • Surgical Procedures Performed

In 2020, Novartis Institute for Tropical Diseases (NITD) discovered malaria therapy.

  • Malaria
  • Drug Development
  • World
  • India
  • South Africa
  • Pharmaceutical Registrations
  • Drug Approval

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Meningococcal
  • Drug Development
  • World
  • India
  • Chongqing Municipality
  • Jiangsu
  • Liaoning
  • HIV AIDS Prevalence
  • HIV AIDS Mortality Rate

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Infectious Disease
  • Drug Development
  • World
  • South Africa
  • Toyama Prefecture
  • Shaanxi
  • Drug Approval
  • Pharmaceutical Registrations

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Japan
  • Drug Approval
  • Pharmaceutical Registrations

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Japan
  • Drug Approval
  • Pharmaceutical Registrations

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Meningococcal
  • World
  • Toyama Prefecture
  • Chongqing Municipality
  • HIV AIDS Prevalence
  • Diagnostic Imaging Density

Inovio Pharmaceuticals announced the publication of a scientif ic paper highlighting positive results f rom the company's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.

  • Infectious Disease
  • World
  • India
  • Drug Approval
  • Surgical Procedures Performed

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Infectious Disease
  • Toyama Prefecture
  • South Africa
  • Shaanxi
  • Indiana
  • Drug Approval
  • HIV AIDS Prevalence

The company stated that ATI-## is eligible f or a Neglected Tropical Disease Priority Review Voucher if f irst approved by the U.S. Food and Drug Administration (FDA) f or the treatment of cryptococcal meningitis

  • Infectious Disease
  • Toyama Prefecture
  • Drug Approval
  • Mortality Rate

The Company has slowed down its development programs in Neglected Tropical Diseases (NTDs) caused by viruses such as Dengue viruses and Rabies during the economic crisis of 2009 in order to conserve resources.

  • Infectious Disease
  • World
  • China
  • South Africa
  • Drug Approval
  • Infectious Disease Mortality